ROHAN PALEKAR - 01 Feb 2025 Form 4 Insider Report for 89bio, Inc. (ETNB)

Role
Chief Executive Officer, Director
Signature
/s/ Ryan A. Murr, as attorney-in-fact for Rohan Palekar
Issuer symbol
ETNB
Transactions as of
01 Feb 2025
Net transactions value
-$92,141
Form type
4
Filing time
04 Feb 2025, 21:32:31 UTC
Previous filing
10 Dec 2024
Next filing
11 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ETNB Common Stock Award $0 +212,000 +45% $0.000000 683,236 01 Feb 2025 Direct F1
transaction ETNB Common Stock Award $0 +200,000 +29% $0.000000 883,236 01 Feb 2025 Direct F2
transaction ETNB Common Stock Tax liability $92,141 -9,598 -1.1% $9.60 873,638 01 Feb 2025 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ETNB Stock Option (Right to Buy) Award $0 +848,000 $0.000000 848,000 01 Feb 2025 Common Stock 848,000 $9.60 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units that vest in equal semi-annual installments over three years, subject to the Reporting Person's continued service to the Issuer.
F2 Represents restricted stock units that vest in equal semi-annual installments over two years, subject to the Reporting Person's continued service to the Issuer.
F3 These shares were withheld from the vesting of restricted stock units to cover the estimated tax withholding obligation.
F4 Represents a right to purchase a total of 848,000 shares of the Issuer's Common Stock, one quarter of which will vest on February 1, 2026, with the remaining three quarters vesting in equal quarterly installments over the following three years, subject to the Reporting Person's continued service to the Issuer.